Home Multiple Sclerosis
Cell Star

Multiple Sclerosis

Multiple Sclerosis (MS) is a chronic, potentially disabling autoimmune disease of the central nervous system (CNS), which includes the brain and spinal cord. In MS, the immune system mistakenly attacks the protective covering of nerve fibers, known as myelin. This damage disrupts the flow of information within the brain, and between the brain and the rest of the body. Over time, the disease can cause permanent damage to the nerves, leading to a wide range of physical and cognitive impairments.

MS affects an estimated 2.8 million people globally, with symptoms and severity varying greatly among individuals. Though there is no known cure, advancements in disease-modifying therapies and regenerative approaches like stem cell therapy and hyperbaric oxygen therapy (HBOT) have brought new hope for better disease management and improved quality of life.

Types of Multiple Sclerosis

There are four main types of MS:

  • Clinically Isolated Syndrome (CIS): A single episode of neurological symptoms lasting at least 24 hours. It may or may not progress to MS.
  • Relapsing-Remitting MS (RRMS): The most common form, characterized by clear relapses (flare-ups) followed by partial or complete recovery (remission).
  • Secondary Progressive MS (SPMS): Initially presents as RRMS but gradually worsens with or without relapses.
  • Primary Progressive MS (PPMS): Steady worsening of neurological function from the onset without distinct relapses or remissions.

Causes and Risk Factors

The exact cause of MS is unknown, but it is believed to result from a combination of genetic and environmental factors:

  • Genetic predisposition: Having a close relative with MS increases the risk.
  • Autoimmune triggers: Viral infections like Epstein-Barr virus (EBV) are implicated.
  • Vitamin D deficiency: Low levels are linked to increased MS risk.
  • Geographic factors: More common in regions farther from the equator.
  • Smoking: Increases the likelihood of developing MS and accelerates its progression.
  • Gender: Women are two to three times more likely to develop MS than men.

Pathophysiology

MS is an immune-mediated condition in which the immune system attacks the myelin sheath—the insulating layer surrounding nerves. This causes inflammation and the formation of scar tissue (sclerosis), which impedes nerve conduction. Over time, axonal damage and loss of brain volume (atrophy) can occur, leading to irreversible disability.

Lesions commonly occur in the optic nerves, brainstem, spinal cord, and cerebellum. The disease process includes episodes of active inflammation and periods of remission or slow progression.

Symptoms

MS symptoms vary depending on the location and severity of lesions. Common symptoms include:

  • Fatigue
  • Numbness or tingling
  • Muscle weakness or spasms
  • Difficulty walking and coordination issues
  • Vision problems (e.g., optic neuritis)
  • Bladder and bowel dysfunction
  • Cognitive changes (e.g., memory, concentration)
  • Emotional disturbances (e.g., depression, anxiety)
  • Sexual dysfunction

Symptoms may come and go in RRMS or progressively worsen in SPMS and PPMS.

Diagnosis

Diagnosis involves a combination of clinical, imaging, and laboratory findings. The McDonald criteria are commonly used to confirm MS.

  • Medical history and neurological exam
  • MRI: Reveals characteristic white matter lesions in the CNS
  • Lumbar puncture: Detection of oligoclonal bands in cerebrospinal fluid
  • Evoked potentials: Measure electrical activity in response to stimuli to assess nerve function

Early diagnosis allows timely initiation of treatment to slow disease progression.

Conventional Treatment

Treatment goals include managing symptoms, modifying disease progression, and improving quality of life.

Disease-modifying therapies (DMTs):

  • Interferon beta (e.g., Avonex, Rebif)
  • Glatiramer acetate
  • Oral medications: Fingolimod, Dimethyl fumarate, Teriflunomide
  • Monoclonal antibodies: Natalizumab, Ocrelizumab, Alemtuzumab

Steroids:

  • Methylprednisolone for managing relapses

Symptom management:

  • Muscle relaxants, antidepressants, pain medications
  • Physical therapy and rehabilitation

Lifestyle and supportive care:

  • Regular exercise, healthy diet, stress management, and adequate sleep

Stem Cell Therapy in MS

Stem cell therapy is gaining attention as a regenerative approach to repair damaged tissues, reset the immune system, and slow disease progression.
Types of stem cells:

  • Hematopoietic stem cells (HSCs): Used in autologous hematopoietic stem cell transplantation (aHSCT)
  • Mesenchymal stem cells (MSCs): Known for their anti-inflammatory and neuroprotective effects

Mechanism of action:

  • Immune system “reset” to eliminate autoreactive cells
  • Promotion of remyelination and neuroregeneration
  • Modulation of inflammatory responses

Clinical evidence:

  • aHSCT has shown positive outcomes in highly active RRMS
  • Studies report reduced relapse rates, MRI lesion activity, and improved disability scores

Risks and considerations:

  • Risk of infection due to immunosuppression
  • Requires specialized centers and experienced clinicians

Hyperbaric Oxygen Therapy (HBOT) for MS

HBOT involves the inhalation of 100% oxygen in a pressurized chamber, improving oxygen delivery to tissues and potentially reducing inflammation and fatigue.

Mechanism:

  • Enhances tissue oxygenation
  • Reduces oxidative stress and inflammation
  • Stimulates angiogenesis and neurogenesis
  • May improve mitochondrial function

Clinical benefits:

  • Some studies report improvement in fatigue, bladder function, and quality of life
  • Evidence remains mixed; not universally accepted as standard treatment

Protocol:

  • Multiple sessions (typically 60–90 minutes each)
  • Frequency varies based on patient condition

Rehabilitation and Holistic Care

MS requires a multidisciplinary approach for optimal management:

  • Physical therapy: Maintains mobility and prevents deconditioning
  • Occupational therapy: Aids in adapting to daily life tasks
  • Speech and cognitive therapy: Helps with speech issues and cognitive deficits
  • Mental health support: Counseling and support groups
  • Diet and nutrition: Anti-inflammatory diets may help manage symptoms

Prognosis

MS is not fatal in most cases, but it can lead to significant disability. Disease course is highly variable. Many people with MS continue to live active lives with appropriate treatment. Life expectancy is slightly reduced, mostly due to complications rather than MS itself.

Conclusion

Multiple Sclerosis is a complex autoimmune disorder with wide-ranging symptoms and unpredictable progression. Advances in immunomodulatory and regenerative treatments such as stem cell therapy and HBOT offer new possibilities for managing the disease beyond symptom control. A comprehensive treatment plan that includes medical therapy, rehabilitation, lifestyle modifications, and psychosocial support can significantly improve outcomes and empower individuals with MS to lead fuller, more independent lives.

Working Time
  • Monday-Saturday 09:00 AM  TO 06:00 PM
Contact Info